Literature DB >> 19670370

Requirements for the valid quantification of immunostains on tissue microarray materials using image analysis.

Christine Decaestecker1, Xavier Moles Lopez, Nicky D'Haene, Isabelle Roland, Saad Guendouz, Christophe Duponchelle, Alix Berton, Olivier Debeir, Isabelle Salmon.   

Abstract

Antibody-based proteomics applied to tissue microarray (TMA) technology provides a very efficient means of visualizing and locating antigen expression in large collections of normal and pathological tissue samples. To characterize antigen expression on TMAs, the use of image analysis methods avoids the effects of human subjectivity evidenced in manual microscopical analysis. Thus, these methods have the potential to significantly enhance both precision and reproducibility. Although some commercial systems include tools for the quantitative evaluation of immunohistochemistry-stained images, there exists no clear agreement on best practices to allow for correct and reproducible quantification results. Our study focuses on practical aspects regarding (i) image acquisition (ii) segmentation of staining and counterstaining areas and (iii) extraction of quantitative features. We illustrate our findings using a commercial system to quantify different immunohistochemistry markers targeting proteins with different expression patterns (cytoplasmic, nuclear or membranous) in colon cancer or brain tumor TMAs. Our investigations led us to identify several steps that we consider essential for standardizing computer-assisted immunostaining quantification experiments. In addition, we propose a data normalization process based on reference materials to be able to compare measurements between studies involving different TMAs. In conclusion, we recommend certain critical prerequisites that commercial or in-house systems should satisfy in order to permit valid immunostaining quantification.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19670370     DOI: 10.1002/pmic.200800936

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  15 in total

1.  Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells.

Authors:  Justine Allard; Ké Li; Xavier Moles Lopez; Stéphane Blanchard; Paul Barbot; Sandrine Rorive; Christine Decaestecker; Roland Pochet; Delphine Bohl; Angelo C Lepore; Isabelle Salmon; Charles Nicaise
Journal:  Regen Med       Date:  2014       Impact factor: 3.806

2.  Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysis.

Authors:  Claudia Röwer; Björn Ziems; Anngret Radtke; Oliver Schmitt; Toralf Reimer; Cornelia Koy; Hans-Jürgen Thiesen; Bernd Gerber; Michael O Glocker
Journal:  Int J Clin Exp Pathol       Date:  2011-02-28

3.  Protein analytical assays for diagnosing, monitoring, and choosing treatment for cancer patients.

Authors:  Alicia D Powers; Sean P Palecek
Journal:  J Healthc Eng       Date:  2012-12       Impact factor: 2.682

4.  Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes.

Authors:  I Marhfour; X M Lopez; D Lefkaditis; I Salmon; F Allagnat; S J Richardson; N G Morgan; D L Eizirik
Journal:  Diabetologia       Date:  2012-06-15       Impact factor: 10.122

5.  Artificial Intelligence-Based Semisupervised Self-Training Algorithm in Pathological Tissue Image Segmentation.

Authors:  Qun Li; Linlin Liu
Journal:  Comput Intell Neurosci       Date:  2022-06-13

6.  A simplified approach for the molecular classification of glioblastomas.

Authors:  Marie Le Mercier; Delfyne Hastir; Xavier Moles Lopez; Nancy De Nève; Calliope Maris; Anne-Laure Trepant; Sandrine Rorive; Christine Decaestecker; Isabelle Salmon
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer.

Authors:  L Ferdinande; C Decaestecker; L Verset; A Mathieu; X Moles Lopez; A-M Negulescu; T Van Maerken; I Salmon; C A Cuvelier; P Demetter
Journal:  Br J Cancer       Date:  2011-11-22       Impact factor: 7.640

8.  IGF-IR: a new prognostic biomarker for human glioblastoma.

Authors:  C Maris; N D'Haene; A-L Trépant; M Le Mercier; S Sauvage; J Allard; S Rorive; P Demetter; C Decaestecker; I Salmon
Journal:  Br J Cancer       Date:  2015-08-20       Impact factor: 7.640

9.  Morphometric and quantitative immunohistochemical analysis of disease-related changes in the upper (suburothelial) lamina propria of the human bladder dome.

Authors:  Thomas Gevaert; Xavier Moles Lopez; Xavier Sagaert; Louis Libbrecht; Tania Roskams; Sandrine Rorive; Christine Decaestecker; Isabelle Salmon; Dirk De Ridder
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

10.  Epithelial expression of FHL2 is negatively associated with metastasis-free and overall survival in colorectal cancer.

Authors:  L Verset; J Tommelein; X Moles Lopez; C Decaestecker; M Mareel; M Bracke; I Salmon; O De Wever; P Demetter
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.